{
    "clinical_study": {
        "@rank": "83860", 
        "arm_group": [
            {
                "arm_group_label": "misoprostol vaginal 200 mcg", 
                "arm_group_type": "Active Comparator", 
                "description": "The study group will receive two doses of misoprostol (200mcg each tablet) vaginal 12 and 4 hours prior insertion After 24 hours of the insertion failure the women will return to the clinic and a new attempt of insertion will be done. At this time we will evaluate if the insertion was able to do or not."
            }, 
            {
                "arm_group_label": "placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "The placebo group will receive two doses of placebo vaginal 12 and 4 hours prior insertion. After 24 hours of the insertion failure the women will return to the clinic and a new attempt of insertion will be done. At this time we will evaluate if the insertion was able to do or not."
            }
        ], 
        "brief_summary": {
            "textblock": "To assess the usefulnes sof misoprostol versus placebo (in a double-blind placebo controlled\n      randomized clinical trial)to facilitate the insertion of copper-IUD and the\n      levonorgestrel-releasing intrauterine system (LNG-IUS) in cases of failure due to cervical\n      stenosis in either nulligravidas and parous women. Additionally to evaluate the side-effects\n      of the misoprostol. The hypothesis is that misoprostol may be better than placebo."
        }, 
        "brief_title": "Use of Misoprostol in Case of Insertion Failure of Intrauterine Contraceptives", 
        "completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Cervical Stenosis", 
        "detailed_description": {
            "textblock": "Women attended at the Family Planning clinic of the University of Campinas who requested the\n      insertion of a copper-IUD or an LNG-IUS and who failed in the attempt due to cervical\n      stenosis will be randomized in two groups (1:1). The study group will receive two doses of\n      misoprostol (200mcg each tablet) vaginal 12 and 4 hours prior insertion and the control\n      group will receive placebo in the same schedule. The sample will be 50 women in each group.\n      After 24 hours of the insertion failure the women will return to the clinic and a new\n      attempt of insertion will be done. At this time we will evaluate if the insertion was able\n      to do or not. The data will be analyzing with \u03c72 test for independent samples. After that a\n      multiple logistic analysis will be perform to evaluate the associated variables with the\n      result (failure or successful) insertion. The level of significance will be established at\n      P<.005."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Women aged > 18 and <50 years old; Requesting insertion of and IUD or an LNG-IUS Failure\n        of IUD insertion\n\n        Exclusion Criteria:\n\n        Refuse to participate Lost to follow-up at the return visit"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "102", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 18, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01754649", 
            "org_study_id": "Unicamp/2012/LB"
        }, 
        "intervention": {
            "arm_group_label": [
                "misoprostol vaginal 200 mcg", 
                "placebo"
            ], 
            "description": "The study group will receive two doses of misoprostol (200mcg each tablet) vaginal 12 and 4 hours prior insertion. After 24 hours of the insertion failure the women will return to the clinic and a new attempt of insertion will be done. At this time we will evaluate if the insertion was able to do or not.", 
            "intervention_name": "Misoprostol", 
            "intervention_type": "Drug", 
            "other_name": "PROSTOKOS"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Contraceptive Agents", 
                "Misoprostol"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "intrauterine device", 
            "insertion failure"
        ], 
        "lastchanged_date": "May 29, 2014", 
        "location": [
            {
                "contact": {
                    "email": "bahamond@caism.unicamp.br", 
                    "last_name": "Luis Bahamondes, MD; PhD", 
                    "phone": "55-19-3289-2856", 
                    "phone_ext": "209"
                }, 
                "contact_backup": {
                    "email": "abarros@cemicamp.org.br", 
                    "last_name": "Adriana Barros", 
                    "phone": "55-19-3289-2856", 
                    "phone_ext": "209"
                }, 
                "facility": {
                    "address": {
                        "city": "Campinas", 
                        "country": "Brazil", 
                        "state": "SP", 
                        "zip": "13084-971"
                    }, 
                    "name": "Family Planning Clinic, University of Campinas"
                }, 
                "investigator": [
                    {
                        "last_name": "Luis Bahamondes, MD; PhD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Maria Valeria Bahamondes, MD;PhD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "bahamond@caism.unicamp.br", 
                    "last_name": "Luis Bahamondes, PhD", 
                    "phone": "55 19 32892856", 
                    "phone_ext": "209"
                }, 
                "facility": {
                    "address": {
                        "city": "Campinas", 
                        "country": "Brazil", 
                        "state": "SP"
                    }, 
                    "name": "University of Campinas"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "2", 
        "official_title": "Assessment of Use of Misoprostol to Facilitate the Insertion of Intrauterine Contraceptives After Failure of Insertion. A Randomized Double-blind Clinical Trial", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Brazil: National Committee of Ethics in Research", 
                "Brazil: Ethics Committee"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The study group will receive two doses of misoprostol (200mcg each tablet) vaginal 12 and 4 hours prior insertion and the control group will receive placebo in the same schedule. The sample will be 50 women in each group. After 24 hours of the insertion failure the women will return to the clinic and a new attempt of insertion will be done. At this time we will evaluate if the insertion was able to do or not.", 
            "measure": "ease of insertion of intrauterine contraceptives", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01754649"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Campinas, Brazil", 
            "investigator_full_name": "Luis Bahamondes", 
            "investigator_title": "PI", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "description": "To assess the side-effects of misoprostol versus placebo", 
            "measure": "Side-effects of misoprostol", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "source": "University of Campinas, Brazil", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Luis Bahamondes", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}